Why the study?
Obesity is a pro-inflammatory process, but the relationship between insulin resistance and less commonly used inflammatory indicators in patients with excess weight needed investigation.
Are neutrophil/lymphocyte ratio, lymphocyte/platelet ratio, and ferritin associated with insulin resistance in obese patients with normal acute phase indicators?
Are neutrophil/lymphocyte ratio, lymphocyte/platelet ratio, and ferritin associated with insulin resistance in obese patients with normal acute phase indicators?
In overweight and obese patients with normal acute phase reactants, increasing BMI is associated with higher insulin resistance, ferritin, and neutrophil-to-lymphocyte ratio, suggesting these markers can indicate early inflammation leading to chronic diseases.
May link underused inflammation markers to insulin resistance in obesity; leaves open prospective validation before clinical adoption.
Introduction: Obesity is a pro-inflammatory process that stimulates the release of inflammatory mediators. The aim of study is to investigate the relationship between insulin resistance and inflammation indicators of obesity, which are not often used in practice, in patients with excess weight. Methods: We conducted a cross-sectional study on 150 patients aged 18 years and older, whose acute phase values were within normal range and were admitted to the Internal Medicine Clinic due to excess weight. We divided the participants into four groups (G1, G2, G3, G4) based on obesity and insulin resistance (HOMA-IR), and analyzed inflammatory markers such as neutrophil lymphocyte ratio (NLR), lymphocyte platelet ratio (LPO) and ferritin. Results: The results showed that all chronic diseases were more common in the G4 group. In particular, there was a significant difference (p<0.05) in the association between HT and hypothyroidism. Weight gain led to an increase in HOMA-IR (3.9±2.2), Ferritin levels (32; range 3-225), and NLO (1.8). Conclusion: This could serve as an inflammation indicator for the transition from obesity to chronic diseases.
No takes yet. Share an insight, caveat, or question.
Hatice Hamarat (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: